Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Roche Holding (OtherRHHBY) and Intuitive Surgical (ISRG)

Tipranks - Tue Feb 10, 5:06PM CST

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding (RHHBYResearch Report) and Intuitive Surgical (ISRGResearch Report).

Valentine's Day Sale - 70% Off

Roche Holding (RHHBY)

TD Cowen analyst Steve Scala maintained a Hold rating on Roche Holding today and set a price target of $67.00. The company’s shares closed last Monday at $57.11.

According to TipRanks.com, Scala is a 5-star analyst with an average return of 11.7% and a 65.0% success rate. Scala covers the Healthcare sector, focusing on stocks such as Elanco Animal Health, GlaxoSmithKline, and Merck & Company. ;'>

Roche Holding has an analyst consensus of Moderate Buy, with a price target consensus of $58.00, a 0.2% upside from current levels. In a report issued on January 26, TipRanks – Anthropic also downgraded the stock to Hold with a $60.00 price target.

See the top stocks recommended by analysts >>

Intuitive Surgical (ISRG)

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Intuitive Surgical, with a price target of $660.00. The company’s shares closed last Monday at $492.84.

According to TipRanks.com, Jennings is a 3-star analyst with an average return of 2.6% and a 46.6% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Anteris Technologies Global Corp., Establishment Labs Holdings, and Orchestra BioMed Holdings. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Intuitive Surgical with a $652.73 average price target, a 34.3% upside from current levels. In a report issued on January 26, BTIG also maintained a Buy rating on the stock with a $616.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.